Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
2023 Oncology Guide to Patient Support Services
MOD_SEARCH_LABEL_TEXT
Coherus BioSciences
2023 Oncology Guide to Patient Support Services
Coherus BioSciences’
Coherus Solutions
offers comprehensive reimbursement and support services for patients receiving treatment with
Udenyca
(pegfilgrastim-cbqv) who are unable to afford this medication.
Read More ›
Daiichi-Sankyo
2023 Oncology Guide to Patient Support Services
Daiichi-Sankyo’s
Access Central
offers comprehensive reimbursement and support services for patients who are prescribed Injectafer or Turalio.
Read More ›
Daiichi-Sankyo & AstraZeneca
2023 Oncology Guide to Patient Support Services
Daiichi-Sankyo and AstraZeneca offer the
Enhertu4U
support program to provide information and assistance to patients who have been prescribed Enhertu.
Read More ›
Eisai
2023 Oncology Guide to Patient Support Services
Eisai offers drug-specific reimbursement assistance to patients taking Halaven or Lenvima.
Read More ›
EMD Serono
2023 Oncology Guide to Patient Support Services
EMD Serono and Pfizer provide the
CoverOne
support services, a set of patient assistance programs that offer reimbursement services, copay assistance, and billing and coding resources for patients who are prescribed
Bavencio
(avelumab), a fully human PD-L1 monoclonal antibody. In addition, the EMD Serono Oncology Navigation Center (ONC) is a patient access and reimbursement support program available to eligible patients who are prescribed
Tepmetko
(tepotinib).
Read More ›
Epizyme
2023 Oncology Guide to Patient Support Services
Epizyme offers the
EpizymeNOW
patient support program for patients who have been prescribed Tazverik.
Read More ›
Exelixis
2023 Oncology Guide to Patient Support Services
Exelixis Access Services (EASE)
includes programs designed to support patients who are prescribed Exelixis oncology drugs Cabometyx or Cometriq.
Read More ›
G1 Therapeutics
2023 Oncology Guide to Patient Support Services
G1 Therapeutics offers the
G1 to One
patient support program to support patients who are prescribed Cosela.
Read More ›
Genentech
2023 Oncology Guide to Patient Support Services
Genentech provides support to help facilitate access to Genentech Oncology medicines for eligible patients.
Read More ›
Gilead Sciences
2023 Oncology Guide to Patient Support Services
Gilead Sciences offers the
Trodelvy Access Support
and the
Zydelig AccessConnect
programs for patients who are prescribed Trodelvy or Zydelig.
Read More ›
GSK
2023 Oncology Guide to Patient Support Services
GSK offers the
Together with GSK Oncology
program for patients who are prescribed a GSK oncology drug.
Read More ›
Helsinn Therapeutics
2023 Oncology Guide to Patient Support Services
Helsinn Therapeutics offers the
Helsinn Cares
program that supports access, reimbursement, and assistance for patients who are prescribed a Helsinn Therapeutics oncology medication.
Read More ›
Immunocore
2023 Oncology Guide to Patient Support Services
Immunocore offers the
KIMMTRAK CONNECT
program to deliver customized support for patients who have been prescribed Kimmtrak.
Read More ›
ImmunoGen
2023 Oncology Guide to Patient Support Services
ImmunoGen offers
Elahere Support Services
to support patients who have been prescribed Elahere.
Read More ›
Incyte
2023 Oncology Guide to Patient Support Services
Incyte offers
IncyteCARES
(Connecting to Access, Reimbursement, Education, and Support) to support patients who have been prescribed
Jakafi
or
Pemazyre
.
Read More ›
Page 2 of 4
1
2
3
4
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Molecular Characteristics Increasingly Define Adult Gliomas
By
William King
2.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
By
William King
3.
Optimal Systemic Therapy for Renal Cell Carcinoma Is Still Evolving
By
William King
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight: Amgen
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes